Stock listing

Copenhagen:EMBLA Embla Medical hf Aktie

Home listing (Copenhagen) of Embla Medical hf

Follow Embla Medical hf into a list and get an email when it puts out news.

Share price · OMXCOP:EMBLA

27.40 DKK +0.05 (+0.2%)

Close on Nov 20, 2026

Past year -18.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
26.95 – 27.75 DKKNov 20, 2026
Volume
239,359 sharesNov 20, 2026
Market cap
11.65B DKKAt the close on Nov 20, 2026 · price × 425.2M shares outstanding
52-week range
25.00 – 37.90 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
2.83M DKKMedian day 55,597 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Embla Medical hf logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Copenhagen:EMBLA · Home27.40 DKK+0.05 (+0.2%)239,35927.0527.7526.9527.35Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:EMBLA · DKK, adjusted for splits

DayCloseChange%OpenHighLowVolume
27.40+0.05+0.2%27.0527.7526.95239,359
27.35-0.05-0.2%27.3527.8027.30117,522
27.40-0.40-1.4%27.8527.9027.20117,264
27.80-0.30-1.1%28.1028.3027.70124,411
28.10+0.20+0.7%27.9028.4527.55158,108
27.90-0.20-0.7%28.5028.8027.80107,288
28.10-0.60-2.1%28.8528.8527.95447,895
28.70+0.75+2.7%28.2028.9028.2087,643
27.95-0.15-0.5%27.6528.1527.651,251,279
28.10+0.85+3.1%27.2028.4027.20839,725
27.25+0.30+1.1%26.9027.3526.8067,216
26.95-0.45-1.6%27.5027.5526.9558,759
27.40+0.40+1.5%27.0027.5527.0055,597
27.00-0.05-0.2%27.1027.7027.0029,181
27.05-0.15-0.6%27.4027.4526.8586,591
27.20+0.45+1.7%26.7527.4026.6053,382
26.75-0.40-1.5%27.1527.5026.7551,043
27.15+0.60+2.3%26.7027.4026.7064,079
26.55+0.35+1.3%26.3026.6526.1565,799
26.20+0.15+0.6%26.0526.2025.5593,782
26.050.000.0%26.0526.7526.00109,778
26.05-1.45-5.3%26.4026.8525.70175,371
27.50-0.15-0.5%27.6528.2527.5036,830
27.65+0.25+0.9%27.3528.4027.3530,113
27.40-0.15-0.5%27.5527.7027.3034,130
27.55+0.35+1.3%27.2527.6027.0034,169
27.20+0.15+0.6%27.1027.5527.0534,384
27.05-0.60-2.2%27.7027.7527.0075,564
27.65-0.10-0.4%27.8028.0027.2574,403
27.75-0.10-0.4%27.8527.8527.5014,144
27.85+0.20+0.7%27.6028.0027.5534,514
27.65+1.00+3.8%26.5027.8526.5051,515
26.65+0.05+0.2%26.6526.9026.4523,533
26.60+0.25+0.9%27.4027.4026.4541,718
26.35-0.80-2.9%27.1527.3026.3546,295
27.15-0.20-0.7%27.3527.5027.0018,856
27.35-0.10-0.4%27.4527.5027.1022,721
27.45+0.10+0.4%27.1527.6527.1519,301
27.350.000.0%27.4027.6027.2515,516
27.350.000.0%27.4527.5027.1026,173
27.35+0.10+0.4%27.1527.6527.1556,672
27.250.000.0%27.6027.7527.0557,386
27.250.000.0%28.0028.0027.1035,525
27.25+0.05+0.2%27.2527.4527.0525,741
27.20+0.15+0.6%27.0027.5527.0042,194
27.05-0.15-0.6%27.2027.3526.5076,964
27.200.000.0%27.0027.5027.0057,255
27.20+0.05+0.2%28.0029.2026.9577,835
27.15-0.55-2.0%27.7027.9026.9079,417
27.70-0.15-0.5%28.2528.3027.4090,431
27.85-0.60-2.1%28.6528.6527.8043,827
28.45+0.05+0.2%28.3528.7028.0535,244
28.40-0.35-1.2%28.0028.7027.5052,672
28.75-0.25-0.9%28.8029.2528.3552,100
29.00-0.05-0.2%29.7529.7528.8084,121
29.05+0.05+0.2%29.0529.2028.8521,679
29.00-0.20-0.7%29.1529.3529.0054,133
29.20-0.20-0.7%29.4029.6029.15141,680
29.40-0.10-0.3%29.5029.6029.1026,208
29.50+0.35+1.2%28.9029.6028.70120,385
29.15-1.00-3.3%30.1030.2528.50185,127
30.15-0.10-0.3%30.3530.4530.1515,979
30.25+0.25+0.8%30.0030.4029.9549,749
30.00+0.25+0.8%29.5530.1029.4559,649
29.750.000.0%29.6529.8029.5526,867
Ticker
Copenhagen:EMBLA
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Copenhagen
Currency
DKK

What changed lately

Latest news

All Embla Medical hf news

Embla Medical hf on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
11 in the last 12 months · 17 in all · newest Jul 17, 2026 · oldest 2025
Calls
9 calls with a replay · 9 with a transcript · latest Jul 21, 2026
Decks
10 decks · latest Oct 20, 2026

Where Embla Medical hf is listed

ListingExchangeCountryCurrency
Copenhagen:EMBLA · Home listing · This pageCopenhagenDenmarkDKK
OTC:OSSUYOTCUnited StatesUSD
LSE:0FIWLSEUnited KingdomDKK
OTC:OSSFFOTCUnited StatesUSD
Frankfurt:5IQFrankfurtGermanyEUR
Aquis:EMBLACAquisUnited KingdomDKK
Aquis:EMBLACAquisUnited KingdomDKK
Turquoise:EMBLACTurquoiseUnited KingdomDKK

Valuation

P/E 18.2× against a median of 20.6×: 5th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
14.41B DKK
P/E
18.2×
EV/sales
2.1×
EV/EBITDA
10.4×
Price/book
1.8×
Gross margin
59.1%
Operating margin
14.0%
Net margin
9.5%
Debt to equity
0.5×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Embla Medical hf · OMXCOP:EMBLAUS$1.71BUS$2.12B18.2×2.1×10.4×1.8×9.5%0.5×n/a
Shandong Weigao Group Medical Polymer Co. Ltd. Class H · HKEX:1066US$1.80BUS$1.20B7.4×0.6×3.0×0.5×12.0%0.2×n/a
Poly Medicure Limited · NSE:POLYMEDUS$1.79BUS$1.70B52.1×7.4×32.6×5.1×14.9%0.0×n/a
Top Glove Corporation Bhd. · MYX:TOPGLOVUS$1.79BUS$1.75B23.8×1.7×9.9×1.5×7.3%0.2×n/a
Medartis Holding AG · SIX:MEDUS$1.69BUS$1.91B170×6.0×58.5×5.0×3.1%0.7×n/a
LeMaitre Vascular, Inc. · NASDAQ:LMATUS$1.68BUS$1.48B26.6×5.5×17.4×3.9×23.5%0.4×0.58
Dentsply Sirona Inc. · NASDAQ:XRAYUS$1.65BUS$3.44Bn/a1.0×12.1×1.2×−3.4%1.5×1.03
Angelalign Technology Inc. · HKEX:6699US$1.60B−US$354.3M5.7×−0.1×−0.7×0.6×9.3%0.2×n/a
Inspire Medical Systems, Inc. · NYSE:INSPUS$1.60BUS$1.27B15.8×1.4×36.9×1.9×11.4%0.0×1.00
Shanghai MicroPort Endovascular MedTech Co., Ltd Class A · SSE:688016US$1.52BUS$1.21B17.4×5.5×n/a2.4×40.1%0.0×n/a
Vitrolife AB · OMXSTO:VITRUS$1.50BUS$1.58Bn/a4.7×n/a1.9×−144.2%0.2×n/a
Median of the othersUS$1.67BUS$1.53B20.6×3.2×14.7×1.9×10.4%0.2×1.00

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
31.90 DKK · Analysts' mean
EPS, year to Dec 2026
1.54 · 5 analysts
Revenue, year to Dec 2026
1.01B · 5 analysts

Team and board

OfficerRole
Sveinn SölvasonPresident and CEO
Klaus SindahlHead of Investor Relations

Events

Next results
Feb 2, 2027 (expected)

Results days

QuarterResultsShare move
Q3 2026Oct 20, 2026 · Before open−5.3%
Q2 2026Jul 21, 2026 · Before open+3.4%
Q1 2026Apr 28, 2026 · After close−0.6%
Q4 2025Feb 3, 2026 · Before open+0.3%
Q3 2025Oct 21, 2025 · Before open+4.4%
Q2 2025Jul 22, 2025 · Before open+0.3%
Q1 2025Apr 29, 2025 · Before open+4.2%
Q4 2024Feb 5, 2025−3.5%
Q3 2024Oct 22, 2024 · Before open0.0%
Q2 2024Jul 23, 2024 · Before open+4.1%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 23, 2024 · Before open+2.0%
Q4 2023Jan 30, 2024 · Before open+4.4%
Q3 2023Oct 24, 2023 · Before open+3.0%
Q2 2023Jul 25, 2023 · Before open+1.7%
Q1 2023Apr 25, 2023 · Before open−1.8%
Q4 2022Jan 31, 2023 · Before open−3.4%
Q3 2022Oct 25, 2022 · Before open−1.8%
Q2 2022Jul 21, 2022 · Before open+5.0%
Q1 2022Apr 26, 2022 · Before open−5.5%
Q4 2021Feb 1, 2022 · Before open+4.1%

Open Events

Decks

DeckKindSlidesDate
Embla Medical — Q3 2026 Earnings PresentationEarnings78 slidesOct 20, 2026
Q2 2026 Earnings PresentationEarnings79 slidesJul 21, 2026
Q1 2026 Earnings PresentationEarnings68 slidesApr 28, 2026
Q4 2025 Earnings PresentationEarnings70 slidesFeb 3, 2026
Q3 2025 Earnings PresentationEarnings12 slidesOct 21, 2025
Q2 2025 Earnings PresentationEarnings13 slidesJul 22, 2025
Q1 2025 Earnings PresentationEarnings12 slidesApr 29, 2025
Q4 2024 Earnings PresentationEarnings12 slidesFeb 5, 2025
Q3 2024 Earnings PresentationEarnings14 slidesOct 22, 2024
Q2 2024 Earnings PresentationEarnings13 slidesJul 23, 2024

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue963.6M854.9M799.1M718.6M718.7M629.5M686.3M612.9M568.6M520.7M
Cost of revenue403.0M320.2M300.1M278.9M263.3M238.3M247.6M226.1M213.8M192.3M
Gross profit560.6M534.7M485.6M439.7M455.4M391.2M438.6M386.8M354.8M328.4M
Research and development41.0M40.8M38.1M34.0M31.7M31.0M31.3M31.4M28.9M23.2M
Selling, general and administrative73.8M70.0M66.9M72.5M74.1M77.7M76.0M70.3M63.7M58.1M
Operating income129.4M112.8M89.4M67.1M95.6M53.3M99.2M90.5M80.5M72.2M
Depreciation and amortization62.9M56.0M49.9M49.4M51.5M64.7M43.6M28.4M22.6M21.7M
EBITDA192.3M168.7M139.3M116.5M147.2M118.0M142.8M118.9M103.0M93.9M
Interest expense21.9M23.2M18.0M11.2M9.80M9.61M8.33M3.76M3.20M2.73M
Income before tax112.0M90.6M76.0M56.2M86.6M12.7M90.3M96.9M68.7M68.4M
Income tax25.2M21.6M17.2M13.0M21.0M4.80M21.4M17.1M11.1M17.4M
Net income86.5M68.3M58.4M42.5M64.0M6.21M66.0M79.8M57.6M51.0M
Earnings per share, basic0.200.160.140.100.150.010.160.190.130.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents102.3M86.2M72.7M76.6M85.2M102.4M58.6M55.7M37.3M35.1M
Receivables153.2M121.9M151.0M131.2M120.7M124.8M131.0M118.4M108.4M96.2M
Inventory165.3M143.1M136.2M132.1M104.0M93.2M112.0M95.9M82.3M75.3M
Current assets457.0M397.0M376.0M348.8M318.2M326.5M307.4M274.0M232.2M210.7M
Goodwill833.7M776.3M690.9M680.4M644.2M612.2M521.0M500.8M414.7M394.1M
Total assets1.74B1.54B1.39B1.33B1.25B1.21B1.09B913.6M793.0M746.4M
Accounts payable32.8M27.3M30.7M28.7M26.7M20.0M26.7M28.1M23.4M17.8M
Current liabilities308.9M209.3M196.2M237.0M186.5M147.3M141.1M117.6M126.8M114.0M
Long-term debt292.2M328.8M311.8M277.7M262.2M340.0M
Total debt541.6M499.8M467.7M480.9M448.2M483.4M360.2M235.5M158.7M154.5M
Total liabilities848.7M758.3M680.7M689.9M620.3M637.1M521.7M376.0M292.6M279.2M
Shareholders' equity888.6M777.2M701.9M635.7M621.6M572.5M564.4M534.5M499.9M466.4M
Shares outstanding427.0M426.7M420.3M417.8M422.8M422.7M424.6M426.5M432.4M440.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations141.8M116.1M94.3M60.8M100.5M92.2M95.3M69.4M73.9M66.3M
Capital spending-22.9M-39.2M-42.3M-25.9M-26.7M-24.0M-31.9M-30.9M-19.2M-24.6M
Free cash flow118.9M76.8M52.0M34.8M73.8M68.2M63.4M38.6M54.7M41.7M
Cash from investing-57.4M-57.1M-66.3M-59.4M-106.4M-62.4M-92.1M-19.4M-86.9M
Cash from financing-72.3M-41.0M3.79M-51.1M51.9M-29.3M44.4M-56.4M31.9M
Dividends paid-9.28M-9.06M-9.18M-7.34M-7.81M
Share buybacks-10.1M00-9.94M0-3.94M-20.6M-19.3M-36.1M-27.8M
Change in cash4.93M17.1M-3.98M-8.57M-17.2M43.8M2.90M18.4M2.18M9.38M

Open Financials

Cap table

Built by 6ix from Embla Medical hf’s releases

Common shares
425,214,514
Fully diluted
425,214,514

Fully diluted

LineShares
Common shares425,214,514

Share count over time

CountShares
Nov 22, 2026425,214,514

Open Cap table

Shareholders

HolderSharesValueAs of
GlacierShares Nasdaq Iceland ETF18,706US$76,678Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Klaus SindahlHead of Investor Relations · Since at least Jul 17, 2026
Sveinn SölvasonPresident and CEO · Since at least Apr 28, 2026

Open People

Log in to ask 6ix AI your own questions about Embla Medical hf.